FOLH1 and prostate cancer: Sensitivity and specificity rates between 64 and 95% and 71 and 95% have been found for PSMA PET/CT and between 67 and 96% and 81 and 100% for PSMA PET/MRI in primary prostate cancer detection [40,41].